Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Mueller

Showing results (201-210 of 220) with videos related to

Pageof 22
Sort By:
Hematology. American Society of Hematology. Education Program|December 10, 2013
The ASH Choosing Wisely®campaign: five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.
Blood|December 6, 2013
The ASH Choosing Wisely® campaign: five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.
Journal of Leukocyte Biology|March 10, 2007
The death-associated protein kinase 2 is up-regulated during normal myeloid differentiation and enhances neutrophil maturation in myeloid leukemic cellsMattia Rizzi, Mario P Tschan, Christian Britschgi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2020
First-in-Human Phase I Study to Evaluate the Brain-Penetrant PI3K/mTOR Inhibitor GDC-0084 in Patients with Progressive or Recurrent High-Grade GliomaPatrick Y Wen, Timothy F Cloughesy, Alan G Olivero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2020
Multiparametric MR-PET Imaging Predicts Pharmacokinetics and Clinical Response to GDC-0084 in Patients with Recurrent High-Grade GliomaBenjamin M Ellingson, Jingwen Yao, Catalina Raymond, et al.
American Journal of Hematology|May 7, 2016
Identifying existing Choosing Wisely recommendations of high relevance and importance to hematologyLisa K Hicks, Anita Rajasekhar, Harriet Bering, et al.
Acta Haematologica|April 15, 2008
Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trialElliott Vichinsky, Zahra Pakbaz, Onyinye Onyekwere, et al.
Blood|December 5, 2014
Five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.
Hematology. American Society of Hematology. Education Program|February 20, 2015
Five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.
The Journal of Infectious Diseases|March 10, 2001
Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudineS Jankelevich, B U Mueller, C L Mackall, et al.
Pageof 22

Showing results (201-210 of 220) with videos related to

Sort By:
Pageof 22
Hematology. American Society of Hematology. Education Program|December 10, 2013
The ASH Choosing Wisely®campaign: five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.
Blood|December 6, 2013
The ASH Choosing Wisely® campaign: five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.
Journal of Leukocyte Biology|March 10, 2007
The death-associated protein kinase 2 is up-regulated during normal myeloid differentiation and enhances neutrophil maturation in myeloid leukemic cellsMattia Rizzi, Mario P Tschan, Christian Britschgi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2020
First-in-Human Phase I Study to Evaluate the Brain-Penetrant PI3K/mTOR Inhibitor GDC-0084 in Patients with Progressive or Recurrent High-Grade GliomaPatrick Y Wen, Timothy F Cloughesy, Alan G Olivero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2020
Multiparametric MR-PET Imaging Predicts Pharmacokinetics and Clinical Response to GDC-0084 in Patients with Recurrent High-Grade GliomaBenjamin M Ellingson, Jingwen Yao, Catalina Raymond, et al.
American Journal of Hematology|May 7, 2016
Identifying existing Choosing Wisely recommendations of high relevance and importance to hematologyLisa K Hicks, Anita Rajasekhar, Harriet Bering, et al.
Acta Haematologica|April 15, 2008
Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trialElliott Vichinsky, Zahra Pakbaz, Onyinye Onyekwere, et al.
Blood|December 5, 2014
Five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.
Hematology. American Society of Hematology. Education Program|February 20, 2015
Five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.
The Journal of Infectious Diseases|March 10, 2001
Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudineS Jankelevich, B U Mueller, C L Mackall, et al.
Pageof 22